Cytek Biosciences (CTKB) Gross Margin (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Gross Margin came in at 48.16% in Q1 2026, down 46.0% YoY from 89.18% in Q1 2025, and down 9.0% on a QoQ basis from 52.92% in Q4 2025.
Cytek Biosciences (CTKB) Gross Margin (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Gross Margin data on file, last reported at 48.16% in Q1 2026.
- Quarterly Gross Margin fell 46.0% year-over-year to 48.16% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 51.7% (down 324.0% YoY) and the FY2025 annual result came in at 51.84%, down 358.0% from the prior year.
- Gross Margin declined to 48.16% in Q1 2026, from 52.92% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 66.36% in Q3 2022 to a low of 48.16% in Q1 2026.
- A 5-year average of 55.77% and a median of 56.62% in 2023 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin jumped 447 bps — and 2023, when it plunged 974 bps.
- Tracing CTKB's Gross Margin over 5 years: stood at 60.77% in 2022, then retreated by 7 bps to 56.75% in 2023, then grew by 3 bps to 58.55% in 2024, then fell by 10 bps to 52.92% in 2025, then decreased by 9 bps to 48.16% in 2026.
- The last three Gross Margin figures came in at 48.16% (Q1 2026), 52.92% (Q4 2025), and 52.69% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 45.84% |
| 10 | Cytek Biosciences | 612.35 Mn | 538.50 Mn | 28.34 Mn | 58.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.87% |
| Mar 31, 2026 | 48.16% |
| Dec 31, 2025 | 52.92% |
| Sep 30, 2025 | 52.69% |
| Jun 30, 2025 | 52.34% |
| Mar 31, 2025 | 48.62% |
| Dec 31, 2024 | 58.55% |
| Sep 30, 2024 | 56.32% |
| Jun 30, 2024 | 54.56% |
| Mar 31, 2024 | 51.30% |
| Dec 31, 2023 | 56.75% |
| Sep 30, 2023 | 56.62% |
| Jun 30, 2023 | 56.67% |
| Mar 31, 2023 | 56.72% |
| Dec 31, 2022 | 60.77% |
| Sep 30, 2022 | 66.36% |
| Jun 30, 2022 | 61.16% |
| Mar 31, 2022 | 57.54% |
| Dec 31, 2021 | 60.77% |
| Sep 30, 2021 | 61.89% |